Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：1
|
作者：
Wyatt, Nicola [1 ]
Hogarth, Linda [1 ]
Turner, Dianne [2 ]
Patterson, Miranda [2 ]
Jamieson, David [1 ]
Black, Fiona [3 ]
Hutton, Claire [1 ]
Mulvenna, Paula [2 ]
Simmons, Tim [2 ]
Bradshaw, Alexander [2 ]
Kolenda, Claire [4 ]
Parker, Craig [4 ]
Martin-Ruiz, Carmen [4 ]
Greystoke, Alastair [1 ]
机构：
[1] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Upon Tyne NHS Fdn Trust, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
[3] Newcastle Upon Tyne NHS Fdn Trust, Dept Pathol, Newcastle Upon Tyne, Tyne & Wear, England
[4] Newcastle Univ, Newcastle Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
frailty; chemotherapy; Biomarkers;
D O I：
10.1016/j.jtho.2016.11.1122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-070
引用
收藏
页码：S829 / S830
页数：2
相关论文
共 50 条
  • [1] Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer
    Holdenrieder, Stefan
    Nagel, Dorothea
    Stieber, Petra
    [J]. CANCER BIOMARKERS, 2010, 6 (3-4) : 179 - 190
  • [2] Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
    Wang, Chin-Chou
    Tseng, Chia-Cheng
    Chang, Huang-Chih
    Huang, Kuo-Tung
    Fang, Wen-Feng
    Chen, Yu-Mu
    Yang, Cheng-Ta
    Hsiao, Chang-Chun
    Lin, Meng-Chih
    Ho, Chi-Kung
    Yip, Hon-Kan
    [J]. ONCOTARGET, 2017, 8 (44) : 75952 - 75967
  • [3] Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
    Indini, Alice
    Rijavec, Erika
    Grossi, Francesco
    [J]. CANCERS, 2021, 13 (08)
  • [4] Bone metastases (BMs) in patients with advanced non-small cell lung cancer (NSCLC): do they always correlate with poor prognosis?
    Rinaldi, S.
    Berardi, R.
    Santoni, M.
    Morgese, F.
    Torniai, M.
    Fiordoliva, I.
    Caramanti, M.
    Paolucci, V.
    Savini, A.
    Onofri, A.
    Santini, D.
    Armento, G.
    Cascinu, S.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 85 - 85
  • [5] EVALUATION OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER (NSCLC)
    FOEMMEL, RS
    ALEXANDER, NA
    HIRSHAUT, Y
    KATOPODIS, N
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 182 - 182
  • [6] Elevated expression of DTYMK is associated with poor prognosis in patients with Non-small cell lung cancer
    Wang, Wei
    Guo, Zhi-Hua
    Lu, Xin-Peng
    Liao, Dong-Jiang
    Peng, Gui-Lin
    Xu, Xin
    Yin, Wei-Qiang
    He, Jian-Xing
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 22027 - 22033
  • [7] Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
    Shun-Dong Dai
    Yan Wang
    Yuan Miao
    Yue Zhao
    Yong Zhang
    Gui-Yang Jiang
    Peng-Xin Zhang
    Zhi-Qiang Yang
    En-Hua Wang
    [J]. BMC Cancer, 9
  • [8] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    X. Zhang
    Z. Wang
    Y. Kang
    X. Li
    X. Ma
    L. Ma
    [J]. Clinical and Translational Oncology, 2014, 16 : 178 - 183
  • [9] Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
    Dai, Shun-Dong
    Wang, Yan
    Miao, Yuan
    Zhao, Yue
    Zhang, Yong
    Jiang, Gui-Yang
    Zhang, Peng-Xin
    Yang, Zhi-Qiang
    Wang, En-Hua
    [J]. BMC CANCER, 2009, 9
  • [10] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    Zhang, X.
    Wang, Z.
    Kang, Y.
    Li, X.
    Ma, X.
    Ma, L.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (02): : 178 - 183
12345